Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by robertshawon Oct 09, 2017 10:44am

149 Views

Post# 26791803

RE:RE:RE:RE:If Dr Frost is our Real Friend and well wisher

Quattro74 wrote: Also, keep in mind so far this is just a small phase 1 HC study. This doesn't become 'real' until we officially get that FDA phase 2 approval. We could get that approval as soon as the 3 month safety data is available on the next six. So perhaps 1st quarter.

Would like to see $400/share when FDA approval, fed up with the fu (king basement and their fu)king boss.

Bullboard Posts

Changing Europe’s dependency on HREE from China